Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Bero to Marketing

This is a "connection" page, showing publications Lisa Bero has written about Marketing.

 
Connection Strength
 
 
 
2.024
 
  1. Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ. 2019 12 12; 367:l6694.
    View in: PubMed
    Score: 0.660
  2. Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. Characteristics and impact of drug detailing for gabapentin. PLoS Med. 2007 Apr; 4(4):e134.
    View in: PubMed
    Score: 0.274
  3. Grundy Q, Held F, MacIsaac M, Baugh CM, Campbell EG, Bero L. Quantifying Industry Spending on Promotional Events Using Open Payments Data. JAMA Health Forum. 2024 Jun 07; 5(6):e241581.
    View in: PubMed
    Score: 0.225
  4. Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open. 2021 02 09; 11(2):e045140.
    View in: PubMed
    Score: 0.179
  5. Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. "There are ways ? drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. Br J Clin Pharmacol. 2021 05; 87(5):2341-2353.
    View in: PubMed
    Score: 0.176
  6. Fabbri A, Holland TJ, Bero LA. Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutr. 2018 12; 21(18):3422-3430.
    View in: PubMed
    Score: 0.151
  7. Grundy Q, Bero LA, Malone RE. Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry. Ann Intern Med. 2016 06 07; 164(11):733-9.
    View in: PubMed
    Score: 0.128
  8. Grundy Q, Bero L, Malone R. Interactions between non-physician clinicians and industry: a systematic review. PLoS Med. 2013 Nov; 10(11):e1001561.
    View in: PubMed
    Score: 0.108
  9. Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93.
    View in: PubMed
    Score: 0.065
  10. Dunsby J, Bero L. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tob Control. 2004 Dec; 13(4):362-9.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)